ISELLA, LUCA
ISELLA, LUCA
Dipartimento di Medicina e Chirurgia
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients
2022-01-01 Buti, Sebastiano; Trentini, Francesca; Sepe, Pierangela; Claps, Melanie; Isella, Luca; Verzoni, Elena; Procopio, Giuseppe
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies
2022-01-01 Santoni, Matteo; Molina-Cerrillo, Javier; Myint, Zin W; Massari, Francesco; Buchler, Tomas; Buti, Sebastiano; Matrana, Marc R; De Giorgi, Ugo; Rizzo, Mimma; Zabalza, Ignacio Ortego; Galli, Luca; Zucali, Paolo Andrea; Aurilio, Gaetano; Incorvaia, Lorena; Bassanelli, Maria; Mammone, Giulia; Salfi, Alessia; Isella, Luca; Mollica, Veronica; Grande, Enrique; Porta, Camillo; Battelli, Nicola
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts
2023-01-01 Santini, Daniele; Banna, Giuseppe Luigi; Buti, Sebastiano; Isella, Luca; Stellato, Marco; Roberto, Michela; Iacovelli, Roberto
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
2022-01-01 Roviello, G; Catalano, M; De Giorgi, U; Maruzzo, M; Buti, S; Gambale, E; Procopio, G; Ottanelli, C; Caliman, E; Isella, L; Sepe, P; Brighi, N; Santoni, M; Galli, L; Conca, R; Doni, L; Antonuzzo, L
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario
2023-01-01 Mazzaschi, Giulia; Giudice, Giulia Claire; Corianò, Matilde; Campobasso, Davide; Perrone, Fabiana; Maffezzoli, Michele; Testi, Irene; Isella, Luca; Maestroni, Umberto; Buti, Sebastiano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients | 1-gen-2022 | Buti, Sebastiano; Trentini, Francesca; Sepe, Pierangela; Claps, Melanie; Isella, Luca; Verzoni, Elena; Procopio, Giuseppe | |
| Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies | 1-gen-2022 | Santoni, Matteo; Molina-Cerrillo, Javier; Myint, Zin W; Massari, Francesco; Buchler, Tomas; Buti, Sebastiano; Matrana, Marc R; De Giorgi, Ugo; Rizzo, Mimma; Zabalza, Ignacio Ortego; Galli, Luca; Zucali, Paolo Andrea; Aurilio, Gaetano; Incorvaia, Lorena; Bassanelli, Maria; Mammone, Giulia; Salfi, Alessia; Isella, Luca; Mollica, Veronica; Grande, Enrique; Porta, Camillo; Battelli, Nicola | |
| Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts | 1-gen-2023 | Santini, Daniele; Banna, Giuseppe Luigi; Buti, Sebastiano; Isella, Luca; Stellato, Marco; Roberto, Michela; Iacovelli, Roberto | |
| Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors | 1-gen-2022 | Roviello, G; Catalano, M; De Giorgi, U; Maruzzo, M; Buti, S; Gambale, E; Procopio, G; Ottanelli, C; Caliman, E; Isella, L; Sepe, P; Brighi, N; Santoni, M; Galli, L; Conca, R; Doni, L; Antonuzzo, L | |
| Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario | 1-gen-2023 | Mazzaschi, Giulia; Giudice, Giulia Claire; Corianò, Matilde; Campobasso, Davide; Perrone, Fabiana; Maffezzoli, Michele; Testi, Irene; Isella, Luca; Maestroni, Umberto; Buti, Sebastiano |